REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,950
+50 (0.46%)
Last updated: May 14, 2025

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 199.92 billion as of May 13, 2025. Its market cap has decreased by -21.07% in one year.

Market Cap
199.92B
Enterprise Value
393.75B
Revenue
148.30B
Ranking
n/a
PE Ratio
48.23
Stock Price
10,950.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 199.92B, an increase of 21.49%. That is a compound annual growth rate of 1.31%.

History

DateMarket Cap% Change
May 13, 2025199.92B-15.11%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 74.02T
Celltrion 33.69T
ALTEOGEN 18.39T
Yuhan 8,026.78B
HLB Co., Ltd. 7,581.42B
SK Biopharmaceuticals 7,079.52B
PharmaResearch 4,171.44B
Peptron 3,872.02B
Market Cap Rankings